Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hysteroscopic Tubal Occlusion with Amcrylate in Hydrosalpinx
NCT02977234Phase 2Unknown
- Sponsor
- Ain Shams University
- Start
- Oct 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of isoamyl 2-cyanoacrylate in hydrosalpinx, sponsored by Ain Shams University. Primary endpoint: Fallopian tubal occlusion at 3 months. Status: unknown.
02
Drugs
isoamyl 2-cyanoacrylate
03
Conditions
hydrosalpinx
Beyond the preview
Go deeper on NCT02977234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02977234.